The Potent Effects of Japan's Stem-cell Policies

Overview

Journal Nature

Specialty Science

Date 2019 Sep 27

PMID 31554988

Citations 9

Authors

David Cyranoski

Affiliations

Soon will be listed here.

Citing Articles

Review Mechanisms for Advanced Medical Therapies in Japan and Thailand: A Proposal for the Use of Expert Clinical Benefit Assessments at Designated Institutions.

Matsui K, Israsena N, Kaewkungwal J, Adams P, Wendler D, Lie R Asian Bioeth Rev. 2025; 17(1):101-115.

PMID: 39896089 PMC: 11785842. DOI: 10.1007/s41649-024-00301-9.

Regenerative rehabilitation: a novel multidisciplinary field to maximize patient outcomes.

Deng C, Aldali F, Luo H, Chen H Med Rev (2021). 2024; 4(5):413-434.

PMID: 39444794 PMC: 11495474. DOI: 10.1515/mr-2023-0060.

Potency Assays: The 'Bugaboo' of Stem Cell Therapy.

Torrents S, Grau-Vorster M, Vives J Adv Exp Med Biol. 2023; 1420:29-38.

PMID: 37258782 DOI: 10.1007/978-3-031-30040-0_3.

Current regenerative medicine-based approaches for skin regeneration: A review of literature and a report on clinical applications in Japan.

Shimizu Y, Ntege E, Sunami H Regen Ther. 2022; 21:73-80.

PMID: 35785041 PMC: 9213559. DOI: 10.1016/j.reth.2022.05.008.

Financial risks posed by unproven cell interventions: Estimation of refunds from medical expense deductions in Japan.

Hatta T, Ide K, Fujita M, Ikka T Stem Cell Reports. 2022; 17(5):1016-1018.

PMID: 35452594 PMC: 9133642. DOI: 10.1016/j.stemcr.2022.03.015.

References

Tsuji K, Sakata Y, Nochioka K, Miura M, Yamauchi T, Onose T . Characterization of heart failure patients with mid-range left ventricular ejection fraction-a report from the CHART-2 Study. Eur J Heart Fail. 2017; 19(10):1258-1269. DOI: 10.1002/ejhf.807. View

Miyamoto S . Japan responds: stem-cell therapy justified. Nature. 2019; 569(7754):40. DOI: 10.1038/d41586-019-01364-7. View

Sipp D, Sleeboom-Faulkner M . Downgrading of regulation in regenerative medicine. Science. 2019; 365(6454):644-646. DOI: 10.1126/science.aax6184. View